Delivery Order SPE2DB22D1106-SPE2DB25FFBR8
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 14, 2025, for Emverm 100 mg tablet chewable unit dose supplies. The contract, valued at $46,543.01, carries a firm fixed price and is scheduled for completion by July 15, 2025. This competitive award, which includes no set-aside designation, is funded through the Defense Logistics Agency's Medical Supply Chain division, supporting federal medical...
- The Defense Logistics Agency awarded a $22,395.03 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. The contract, which is classified as a child award under a larger indefinite delivery vehicle, requires performance completion by June 20, 2025, with fulfillment at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without any set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for supply of Emverm 100 mg tablet chewable unit dose formulations. This competitively awarded, non-set-aside contract carries a ceiling value of $4,208.18 under a firm fixed price arrangement, with an ultimate completion date of June 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,214.32 to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 12, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,427.06 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under a firm fixed price contract type. This non-set-aside award was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor for the DLA and is a major pharmaceutical distributor specializing in medical supply chain support for federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,326.13 delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a $2,984.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the...
- The Defense Logistics Agency awarded a delivery order valued at $18,131.18 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBR8Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Emverm 100 mg tablet chewables, with a ceiling value of $32,123.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded to the contractor. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and holds a significant position in federal medical procurement as a critical vendor for the military and veteran healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 8/5/25 |